Polycystic kidney disease: Tolvaptan in ADPKD-TEMPO 3:4 trial results
- PMID: 23183839
- DOI: 10.1038/nrneph.2012.236
Polycystic kidney disease: Tolvaptan in ADPKD-TEMPO 3:4 trial results
Comment on
-
Tolvaptan in patients with autosomal dominant polycystic kidney disease.N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources